Eklampsia dan Sindroma HELLP pada Kehamilan Awal: Penegakan Diagnosis dan Manajemen Anestesia
Abstract
Preeklampsia merupakan salah satu penyebab morbiditas dan mortalitas ibu hingga saat ini. Penyakit ini memiliki beberapa bentuk manifestasi klinis yang merupakan gambaran dari perburukan dari preeklampsia diantaranya adalah eklampsia dan sindroma HELLP (hemolysis, elevated liver enzyme dan low platelet). Kedua perburukan preeklampsia tersebut biasa terjadi pada usia kehamilan 27 hingga 37 minggu, namun semakin dini onset penyakit ini muncul prognosis bagi ibu akan semakin buruk. Seorang perempuan usia 34 tahun, gravida 3 paritas 1 abortus 1 hamil 24 minggu, janin intra uterine fetal death. Pasien datang dikarenakan kejang seluruh badan selama 5 menit sekitar 30 menit yang lalu sebelum masuk rumah sakit. Berdasarkan pemeriksaan fisik didapatkan hipertensi dengan tekanan darah 180/110 mmHg. Selain itu dari pemeriksaan penunjang didapatkan trombositopenia 94.000, SGOT 350 IU/L and SGPT 285 IU/L. Pasien didiagnosis dengan eklampsia dan sindroma HELLP, kemudian dilakukan terminasi kehamilan melalui seksio sesarea darurat dengan anestesia umum. Pembahasan: manajemen anestesia pada ibu hamil dengan eklampsia dan sindroma HELLP memiliki beberapa pertimbangan khusus antara lain adanya kesulitan intubasi, kemungkinan terjadinya peningkatan tekanan intrakranial dan juga efek pemberian anti kejang terhadap kontraksi rahim. Melalui penegakan diagnosis dan pengenalan risiko yang mungkin dapat terjadi pada pasien dengan eklampsia dan sindroma HELLP dapat direncanakan tindakan dan manajemen anestesia yang lebih baik sehingga morbiditas dan mortalitas ibu dengan eklampsia dan sindroma HELLP dapat diturunkan.
Eclampsia and HELLP Syndrome in Early Pregnancy: Diagnosis and Management of Anesthesia
Abstract
Preeclampsia is one of the leading cause maternal morbidity and mortality. It has various clinical manifestations that describe the severity of the disease include eclampsia and HELLP syndrome (hemolysis, elevated liver enzyme dan low platelet). Those worsening of preeclampsia usually happen during 27 to 37 weeks of gestation. Even though the earlier the onset showed the worse the prognosis is. A pregnant woman 34 years old, gravidy 3 parity 1 abortus 1, 24 weeks gestational age with intra uterine fetal death. Patient had chief complain for seizure before admission. From the physical examination found that patient has severe hypertension with blood pressure 180/110 mmHg. The laboratory result showed trombositopenia 94.000, SGOT 350 IU/L and SGPT 285 IU/L. Patient diagnosed with eclampsia and HELLP syndrome and then did emergency caesarean section with general anesthesia. Discussion: The anesthesia management in this case should be specifics due to the patient condition circumstances with eclampsia and HELLP syndrome. We should prepare for difficult airway, intracranial pressure increase and effect of anticonvulsant agent to the uterine tone. By diagnose and identify the risk of eclamptic and HELLP syndrome patient carefully we can plan the better procedure and anesthesia management that maternal morbidity and mortality can be reduced.
Downloads
References
Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy Guideline. American College of Obstetricians and Gynecologists; 2014.
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Canadian Hypertensive Disorders of Pregnancy Working G, et al. The hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29(5):643-57.
Cunningham FG and Gant N. “William Obstetrics” 24th ed. McGraw-Hill, Medical Publishing Division, 2014; 706-56.
Dilmy MA and Purwosunu Y. Prevalence and characteristics of hypertensive disorder in pregnancy at Cipto Mangunkusumo National General Hospital in 2016. Indonesian J. Obstet. gynecol. 2017;12: 35-37.
Hypertension Guideline Committee; Strategic Training Initiative in Research in The Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(3).
RCOG. Green Top Guideline: The management of pre-eclampsia/eclampsia. Royal College of Obstetricians and Gynaecologists. Guideline no 10 (A), 2006.
L. Weinstein, Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy, Am. J. Obstet. Gynecol. 142 (1982) 159–167.
L. Weinstein, Preeklampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia, Obstet. Gynecol. 66 (1985) 657–660.
A.K. Ertan, S. Wagner, H.J. Hendrik, H.A. Tanriverdi, W. Schmidt, Clinical and biophysical aspects of HELLP-syndrome, J. Perinat. Med. 30 (2002) 483–489.
B.M. Sibai, M.K. Ramadan, I. Usta, M. Salama, B.M. Mercer, S.A. Friedman, Maternal morbidity andmortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), Am. J. Obstet. Gynecol. 169 (1993) 1000–1006.
Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004; 103:981-91.
Douglas M. The use of neuraxial anesthesia in parturients with thrombocytopenia: what is an adequate platelet count? In Halpern S, Douglas M, editors. Evidence-Based Obstetric Anaesthesia. Oxford, Blackwell Publishing, 2005:165-77.
Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev 2010; (9):CD008148.
Barton J, Sibai B. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004; 31:807-33.
Vigil-De Gracia P, Ortega-Paz L. Pre-eclampsia/eclampsia and hepatic rupture. Int J Gynaecol Obstet 2012; 118:186-9.
Sheikh RA, Yasmeen S, Pauly MP, Riegler JL. Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome: four cases and a review. J Clin Gastroenterol 1999; 28:323-8.
Bateman BT and Polley LS. Hypertensive Disorders. In: Chestnuts DH, Wong CA, Tsen LC, Ngan Kee WD, Beilin Y, Mhyre JM, editors. Chestnut’s Obstetric Anesthesia Principles and Practice, 5th ed. Philadelphia: Elsevier Saunders, 2014. 915-31.
Ramanathan J, Bennett K. Pre-eclampsia: fluids, drugs, and anesthetic management. Anesthesiol Clin North Am 2003; 21:145-63.
Stempel JE, O’Grady JP, Morton MJ, Johnson KA. Use of sodium nitroprusside in complications of gestational hypertension. Obstet Gynecol 1982; 60:533-8.
Hood DD, Dewan DM, James FM 3rd. The use of nitroglycerin in preventing the hypertensive response to tracheal intubation in severe preeklampsia. Anesthesiology 1985; 63:329-32.
Ramanathan J, Sibai BM, Mabie WC. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeklampsia. Am J Obstet Gynecol 1988; 159:650-4.
Baker AB. Management of severe pregnancy-induced hypertension, or gestosis, with sodium nitroprusside. Anaesth Intensive Care 1990; 18:361-5.
Ngan Kee WD, Khaw KS, Ma KC. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial. Anesthesiology 2006; 104:14-20.
American College of Obstetricians and Gynecologists Taskforce on Hypertension in Pregnancy. Hypertension in pregnancy. ACOG. Washington, DC, 2013.












Jurnal Anestesi Obstetri Indonesia